Skip to main content
XENE logo
XENE
(NASDAQ)
Xenon Pharmaceuticals Inc.
$56.85-- (--)
Loading... - Market loading

Xenon Pharmaceuticals (XENE) Stock Price & Financial Analysis

Xenon Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$55.86 - $57.44
52-Week High$63.95
52-Week Low$26.74
Open$56.00
Volume897.23K
Average Volume (3M)897.23K
Market Cap4.51B
Shares Outstanding79.25M
Price to Sales (P/S)599.05
Price to Book (P/B)7.72
EV/EBITDA-11.77
Revenue (TTM)7.50M
Net Income (TTM)-345.91M
Free Cash Flow (TTM)-279.92M
EPS (TTM)$-4.36
Profit Margin-4612.13%
Operating Margin-4974.27%
Return on Equity (ROE)-59.46%
Debt to Equity0.01
50-Day MA$47.38
200-Day MA$40.64
52-Week Change85.02%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Xenon Pharmaceuticals

What is the current stock price for XENE?

As of the latest trading session, XENE stock trades at $56.85. The 52-week range is $26.74–$63.95, with a day range of $55.86–$57.44.

What is the P/E ratio for XENE?

The P/E ratio (Price-to-Earnings) for XENE is shown in the Key Statistics section. This valuation metric helps compare Xenon Pharmaceuticals Inc. to industry peers.

Does XENE pay dividends?

Xenon Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for XENE?

Based on 8 analysts, the consensus for XENE is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of XENE?

Xenon Pharmaceuticals's market capitalization is $4.51B, classifying it as a mid-cap company. Xenon Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.